Basics ABBVIE INC. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders. IPO Date: December 14, 2012 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $342.01B Activated in VL: True Average Daily Range Avg Daily Range: $0.97 | 1.02% Avg Daily Range (30 D): $3.67 | 1.94% Avg Daily Range (90 D): $2.52 | 1.31% Institutional Daily Volume Avg Daily Volume: 6.33M Avg Daily Volume (30 D): 6.92M Avg Daily Volume (90 D): 5.28M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 60,252 Avg Inst. Trade: $9.41M Avg Inst. Trade (30 D): $24.29M Avg Inst. Trade (90 D): $23.2M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 19 Market Closing Trades Avg Closing Trade: $86.9M Avg Closing Trade (30 D): $261.34M Avg Closing Trade (90 D): $232.45M Avg Closing Volume: 794.58K         News May 8, 2025 @ 2:55 PM Contract Research and Manufacturing Services (CRAM... Source: N/A May 7, 2025 @ 3:00 PM Generic Oncology Drugs Market Size Estimated to Re... Source: Statifacts May 5, 2025 @ 5:53 PM Cerevel Therapeutics Holdings, Inc. Sued for Secur... Source: N/A May 4, 2025 @ 8:49 AM Is the Trump Administration About to Cause AbbVie,... Source: Keith Speights May 3, 2025 @ 12:37 PM Invest in These ETFs to Prepare Your Portfolio for... Source: Mark Roussin, Cpa Financials   TTM Q3 2024 Q2 2024 Basic EPS $2.87 $.88 $.77 Diluted EPS $2.87 $.88 $.77 Revenue $ 55.53B $ 14.46B $ 14.46B Gross Profit $ 37.32B $ 10.25B $ 10.26B Net Income / Loss $ 5.13B $ 1.56B $ 1.37B Operating Income / Loss $ 13.82B $ 3.83B $ 4B Cost of Revenue $ 18.21B $ 4.21B $ 4.2B Net Cash Flow $ -6030M $ -5873M $ -4937M PE Ratio 64.32